Teratogenicity of the newer antiepileptic drugs – the Australian experience

[1]  J. Stockman.  Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects , 2013 .

[2]  S. Mayer,et al.  Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) , 2011, The Lancet Neurology.

[3]  T. Tomson,et al.  Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.

[4]  F. Vajda.  The Australian Pregnancy Register of Anti-epileptic Drugs : 10 years of progress , 2010, Journal of Clinical Neuroscience.

[5]  M. Eadie,et al.  Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register , 2010, Seizure.

[6]  T. Tomson,et al.  Teratogenic effects of antiepileptic medications. , 2009, Neurologic clinics.

[7]  B. Irwin,et al.  Topiramate in pregnancy , 2006, Neurology.

[8]  C. Bearer.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2007 .

[9]  B. Irwin,et al.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  Ettore Beghi,et al.  Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines , 2004, The Lancet Neurology.

[11]  T. Tomson.  Drug selection for the newly diagnosed patient: When is a new generation antiepileptic drug indicated? , 2004, Journal of Neurology.

[12]  E. Perucca.  Clinical pharmacology and therapeutic use of the new antiepileptic drugs , 2001, Fundamental & clinical pharmacology.

[13]  P. Patsalos.  Pharmacokinetic profile of levetiracetam: toward ideal characteristics. , 2000, Pharmacology & therapeutics.

[14]  M. Riley,et al.  Birth Defects in Victoria 1983–1998 , 2000 .